SCHEMBL18564765

SCHEMBL18564765

CN(c1ccccc1)c1ccc(-c2ccc(-c3ccc4c5ccccc5n(-c5ccc(-c6ccccc6)cc5)c4c3)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ATM Q13315 1/20 0.46
HDAC4 P56524 1/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39
REN P00797 1/20 0.37
TSPO P30536 1/20 0.36
CHKA P35790 2/20 0.35
AVPR1A P37288 1/20 0.35
PDE5A O76074 2/20 0.35
MAOB P27338 1/20 0.35
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 2/20 0.34
IL1R1 P14778 1/20 0.34
GFER P55789 1/20 0.34
AKR1C4 P17516 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
AKR1C1 Q04828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18564820 1.00 KDM4E (0.46) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL10052387 0.99 KDM4E (0.47) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL19735350 0.96 KDM4E (0.51) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL18564745 0.96 KDM4E (0.51) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL18564665 0.96 KDM4E (0.51) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL18564783 0.94 KDM4E (0.46) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL19735329 0.93 KDM4E (0.47) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL18564889 0.92 ATM (0.44) KDM4EL3MBTL1ATMRXRARXRB
SCHEMBL18564883 0.92 ATM (0.44) KDM4EL3MBTL1ATMRXRARXRB
SCHEMBL18564779 0.92 KDM4E (0.46) KDM4EL3MBTL1ATMHDAC4REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 KDM4E 225/4885L3MBTL1 1263/4885ATM 3092/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 KDM4E 225/4885L3MBTL1 1263/4885ATM 3092/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.